Plain-English translation of NCT06315231 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing edaravone dexborneol, a medication taken as a tablet placed under the tongue, to see if it can help restore thinking and memory problems that happen after an acute ischemic stroke. Right now, doctors don't have many proven treatments for these cognitive problems, so researchers want to find out whether this medication can help patients recover their mental abilities.
Many people who survive a stroke experience problems with memory, concentration, and thinking that can seriously affect their quality of life. There are very few proven treatments available for these cognitive problems, so this trial is exploring whether this medication might help protect the brain and improve recovery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to take either the new medication or a placebo (a dummy tablet with no active ingredient) twice daily for 24 weeks. You cannot choose which group you are in, and neither you nor the researchers will know which treatment you are receiving. During the study, you will return for visits where researchers will check your thinking, memory, and brain function using standard tests.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China